Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VLA15 Lyme Disease Vaccine Study in Healthy Adults
NCT07226882Phase 3Active, not recruiting
- Sponsor
- Pfizer
- Start
- Nov 2025
- Primary completion
- Jan 2028
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of VLA15 in Lyme disease, sponsored by Pfizer. Started Nov 2025; status: active, not recruiting.
02
Drugs
VLA15
03
Conditions
Lyme disease
Beyond the preview
Go deeper on NCT07226882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07226882.